Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,169,747
-
Share change
-
+669,030
-
Total reported value
-
$202,346,742
-
Price per share
-
$14.28
-
Number of holders
-
44
-
Value change
-
+$9,508,195
-
Number of buys
-
32
-
Number of sells
-
7
Institutional Holders of TCR2 THERAPEUTICS INC - COM (TCRR) as of Q4 2019
As of 31 Dec 2019,
TCR2 THERAPEUTICS INC - COM (TCRR) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,169,747 shares.
The largest 10 holders included
MPM ASSET MANAGEMENT LLC, MPM ONCOLOGY IMPACT MANAGEMENT LP, Redmile Group, LLC, ArrowMark Colorado Holdings LLC, BlackRock Inc., VANGUARD GROUP INC, Artal Group S.A., HILLHOUSE CAPITAL ADVISORS, LTD., EcoR1 Capital, LLC, and JPMORGAN CHASE & CO.
This page lists
44
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.